KS
Insider buying
Kathleen Sebelius bought $50K of Humacyte, Inc. (HUMAW) stock
Kathleen Sebelius, Dir of Humacyte, Inc. (HUMAW), bought 56,818 shares of HUMAW stock worth $50K, per an SEC Form 4 filed May 20, 2026.
It was an open-market purchase.
The trade happened on May 19, 2026, 1 day before it was made public.
- Traded
- May 19, 2026
- Disclosed
- May 20, 2026
- Filing delay
- 1 day
- Role
- Dir
- Source
- SEC Form 4
More HUMAW insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.